Share this
Shoreline Biosciences Closes $140 Million Funding
Sixth Street Invests in Blueprint Medicines
Billtrust to Combine With South Mountain, a Special Purpose Acquisition Company, at $1.3 Billion Value
Oberland Capital in financing of Agenus
AcelRx sale of Zalviso® royalties to PDL BioPharma
Renovate America Series F financing
TPG Special Situations Partners purchase of Kadcyla® royalties from ImmunoGen
Volcano Corp. Acquired by Royal Philips NV for $1.2 Billion
Volcano Acquired by Philips for $1.2 Billion
Insys Therapeutics IPO